Список литературы

    1. Балашевич, Л.И. Эффективность диодной субпороговой микроимпульсной лазеркоагуляции при лечении различных форм центральной серозной ретинопатии / Л.И. Балашевич, М.В. Гацу, Н.Г. Искендерова / Круглый стол «Макула – 2010» : Тезисы докладов IV Всероссийского семинара. – Ростов-на-Дону, 2010. – С. 416-418.

    2. Большунов, А.В. Субпороговые технологии лазерного лечения макулярной патологии (транспупиллярная термотерапия, субпороговая микроимпульсная лазеркоагуляция) / А.В. Большунов, Н.А. Федорук, А.А. Федоров / Вопросы лазерной офтальмологии. – Москва, 2013. – С. 230-248.

    3. Гацу, М.В. Фотодинамическая терапия – метод выбора при лечении хронических форм центральной серозной хориоретинопатии / М.В. Гацу / Круглый стол «Макула – 2010» : Тезисы докладов IV Всероссийского семинара. – Ростов-на-Дону, 2010. – С. 427-429.

    4. Гацу, М.В. Эффективность фотодинамической терапии при хронических формах центральной серозной хориоретинопатии. Причины неудач / М.В. Гацу / Круглый стол «Макула – 2010» : Тезисы докладов IV Всероссийского семинара. – Ростов-на-Дону, 2014. – С. 139-155.

    5. Гонта, А. Характеристики изображения: контраст, динамический диапазон, резкость / А. Гонта / Алгоритм безопасности. – 2006. – № 5. – С. 56-60.

    6. Дога, А.В. Диагностическая ценность измерения толщины хориоидеи у пациентов с субмакулярной неоваскулярной мембраной / А.В. Дога, Д.А. Магарамов, В.А. Соломин / Офтальмохирургия. – 2014. – № 2. – С. 40-43.

    7. Дога, А.В. Центральная серозная хориоретинопатия: современные аспекты диагностики и лечения / А.В. Дога, Г.Ф. Качалина, О.Б. Клепинина. – Москва: Офтальмология, 2017. – С. 171-212.

    8. Злобина, А.Н. Клинико-патогенетическое обоснование диагностических и классификационных критериев центральной серозной хориоретинопатии : дис. … канд. мед. наук: 14.01.07 / Злобина А.Н. – Москва, 2015. – 122 с.

    9. Значение метода аутофлюоресценции в диагностике патологии глазного дна / С.Э. Аветисов, Т.Н. Киселева, М.В. Воробьева [и др.] / Вестник офтальмологии. – 2011. – № 5. – С. 49-53.

    10. Зольникова, И.В. Мультифокальная электроретинография в диагностики наследственных и возрастных дегенераций сетчатки : дис. … д-ра мед. наук: 14.01.07 / Зольникова И.В. – Москва 2012. – 329 с.

    11. Клепинина, О.Б. Субпороговое микроимпульсное лазерное воздействие длиной волны 577Нм при лечении центральной серозной хориоретинопатии: дис. … канд. мед. наук: 14.01.07 / Клепинина О.Б. – Москва, 2014. – 143 с.

    12. Макулярные паттерн-дистрофии / Ф.Е. Шадричев, Н.Н. Григорьева, В.В. Рахманов [и др.] / Офтальмологические ведомости. – 2009. – Т. II, № 2. – С. 96-101.

    13. Мирзабекова, К.А. Лазеры в лечении центральной серозной хориоретинопатии / К.А. Мирзабекова, Н.А. Федорук / Вопросы лазерной офтальмологии. – Москва, 2013. – С. 249-255.

    14. Мутиков, И.В. Отдаленные разультаты лечения центральной серозной хориоретинопатии (ЦСХРП) с юкста-субфовеолярной локализацией точки фильтрации с помощью субпорогового микроимпульсного инфракрасного лазерного воздействия (СМИЛВ) / И.В. Мутиков, И.Ю. Мазунин, А.Ю. Павлова / Практическая медицина. – 2012. – № 4. – С. 123-127.

    15. Новиков, П.В. Правовые аспекты редких (орфанных) заболеваний в России и в мире / П.В. Новиков / Медицина. – 2013. – № 4. – С. 53-73.

    16. Основы этиопатогенеза наследственных моногенных болезней сетчатки / Н.А. Беклемищева, О.В. Хлебникова, Е.Л. Дадали, И.В. Угаров / Медицинская генетика. – 2005. – Т. 4, № 7. – С. 300-306.

    17. Педанова, Е.К. Соответствие данных индоцианин-зеленой ангиографии и ОКТ-ангиографии в диагностике неоваскуляризации при хронической центральной серозной хориоретинопатии / Е.К. Педанова, О.Б. Клепинина, Д.А. Буряков / Офтальмология. – 2018. – Т. 15, № 2S. – С. 254-260. – doi.org/10.18008/1816-5095-2018-2S-254-260.

    18. Показания и эффективность различных методов лечения хронической центральной серозной хориоретинопатии / А.Н. Злобина, В.В. Малышев, Т.Н. Юрьева, А.Г. Щуко / Практическая медицина. – 2012. – № 4. – С. 105-107.

    19. Саакян, С.В. Меланомаассоциированная вителлиформная ретинопатия (клиническое наблюдение) / С.В. Саакян / Вестник офтальмологии. – 2017. – № 4. – С. 61-66. – doi:10.17116/oftalma201813404161.

    20. Соломин В.А. Современные неинвазивные методы диагностики и комбинированного лечения пациентов с субмакулярной неоваскулярной мембраной : дис. … канд. мед. наук: 14.01.07 / Соломин В.А. – Москва, 2014. – 129 с.

    21. Трухачева, H.В. Медицинская статистика в медико-биологических исследованиях пакета Stasistica / H.В. Трухачева. – ГЭОТАР-медиа, 2013. – С.84-85.

    22. Улитина, А.Ю. Оценка толщины хориоидеи при возрастной макулярной дегенерации / А.Ю. Улитина, А.С. Измайлов / Вестник ОГУ. – 2013. – № 4. – С. 275-279.

    23. Центральная серозная хориоретинопатия с позиций ОКТ-ангиографии. Част 1. Изменение хориоретинального кровотока / А.Г. Щуко, С.И. Жукова, Т.Н. Юрьева, А.Н. Злобина / Офтальмология. – 2018. – Т. 15, № 3. – С. 294-302.

    24. Щеголева, И.В. Этиология и патогенез центральной серозной хориоретинопатии / И.В. Щеголева, М.В. Будзинская / Вестник офтальмологии. – 2010. – № 3. – С. 55-58.

    25. A novel mutation in the RDS/Peripherin gene causes adult-onset foveomacular dystrophy / Z. Yang, W. Lin, D. Moshfeghi [et al.] / Am. J. Ophthalmol. – 2003. – Vol. 135, № 2. – P. 213-218. – doi: 10.1016/s0002-9394(02)01815-9.

    26. A peripherin/retinal degeneration slow mutation (Pro-210-Arg) associated with macular and peripheral retinal degeneration / M.B. Gorin, K.E. Jackson, R.E. Ferrell [et al.] / Ophthalmol. – 1995. – Vol. 102. – P. 246-255. – doi: 10.1016/s0161-6420(95)31029-9.

    27. Acuired vitelliform lesions / K. Freund, K. Laud, L. Lima [et al.] / Retina. – 2011. – Vol. 31, № 1. – P. 13-25. – doi: 10.1097/iae.0b013e3181ea48ba.

    28. Acute central serous chorioretinopathy: a correlation study between fundus autofluorescence and spectral-domain OCT / P. Iacono, P.M. Battaglia, A. Papayannis [et al.] / Graefes Arch. Clin. Exp. Ophthalmol. – 2015. – Vol. 253, № 11. – P. 1889-1897. – doi: 10.1007/s00417-014-2899-5.

    29. Adult-jnset foveomacular pigment epithelial dystrophy: Clinicopathologic Correlation of Three Cases / S. Dubovy, R. Hairston, H. Schatz [et al.] / Retina. – 2000. – Vol. 20, № 6. – P. 638-649. – doi: 10.1097/00006982-200006000-00010.

    30. Adult-onset foveomacular vitelliform dystrophy: A fresh perspective / I. Chowers, L. Tiosano, I. Audo [et al.] / Prog. Retin Eye Res. – 2015. – Vol. 47. – P. 64-85.

    31. Adult-onset foveomacular vitelliform dystrophy: a study by optical coherence tomography / N. Benhamou, E. Souied, R. Zolf [et al.] / Am. J. Ophthalmol. – 2003. – Vol. 135, № 3. – P. 362-367. – doi: 10.1016/s0002-9394(02)01946-3.

    32. Adult-onset foveomacular vitelliform dystrophy evaluated by means of optical coherence tomography angiography: A Comparison With Dry Age-Related Macular Degeneration and Healthy Eyes / L. Toto, E. Borrelli, R. Mastropasqua [et al.] / Retina. – 2018. – Vol. 38, № 4. – P. 731-738. – doi: 10.1097/IAE. 0000000000001615.

    33. Adult vitelliform macular degeneration: a clinicopathological study / J. Arnold, J. Sarks, M. Killingsworth [et al.] / Eye. – 2003. – Vol. 17, № 6. – P. 717-726. – doi: 10.1038/sj.eye.6700460.

    34. Agarwal, A. Gass's Atlas of Macular Diseases / A. Agarwal. – 5 ed. – Elsevier, 2012. – 1378 p.

    35. Akkaya, S. Spectrum of pachychoroid diseases / S. Akkaya / Int. Ophthalmol. – 2018. – Vol. 38, № 5. – P. 2239-2246. – doi: 10.1007/s10792-017-0666-4.

    36. Alexithymia and emotional distress in patients with central serous chorioretinopathy / R. Conrad, N.F. Weber, M. Lehnert [et al.] / Psychosomatics. – 2007. – Vol. 48. – P. 489-495.

    37. Alfonso-Munoz, E. Bestrophinopathy mimicking central serous chorioretinopathy / E. Alfonso-Munoz, R. Dolz-Marco / Ophthalmol. Retina. – 2018. – Vol. 2. – P. 857.

    38. Alterations of intraretinal layers in acute central serous chorioretinopathy / C. Ahlers, W. Geitzenauer, G. Stock [et al.] / Acta Ophthalmol. – 2009. – Vol. 87. – P. 511-516.

    39. Alterations of retinal pigment epithelium in central serous chorioretinopathy / Y. Hirami, A. Tsujikawa, M. Sasahara [et al.] / Clin. Exp. Ophthalmol. – 2007. – Vol. 35. – P. 225-230.

    40. An association between central serous chorioretinopathy and gastroesophageal reflux disease / C.C. Mansuetta, J.O. Mason 3rd, J. Swanner [et al.] / Am. J. Ophthalmol. – 2004. – Vol. 137. – P. 1096-1100.

    41. Arora, S. Implementation of the new multimodal imaging-based classification of central serous chorioretinopathy / S. Arora, A.N. Kulikov, D.S. Maltsev / Eur. J. Ophthalmol. – 2021. – Vol. 11206721211013651. – doi: 10.1177/ 11206721211013651. Epub ahead of print.

    42. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy / P. Jirarattanasopa, S. Ooto, A. Tsujikawa [et al.] / Ophthalmol. – 2012. – Vol. 119, № 8. – P. 1666-1678. – doi: 10.1016/ j.ophtha.2012.02.021.

    43. Association of choroidal neovascularization and central serous chorioretinopathy with optical coherence tomography angiography / M.A. Bonini Filho, T.E. de Carlo, D. Ferrara [et al.] / JAMA Ophthalmol. – 2015. – Vol. 133, № 8. – P. 899-906. – doi: 10.1001/jamaophthalmol.2015.13205.

    44. Association of Helicobacter pylori with central serous cho- rioretinopathy in Iranian patients / M. Roshani, N.A. Davoodi, M.R. Seyyedmajidi [et al.] / Gastroenterol. Hepatol. Bed Bench. – 2014. – Vol. 7. – P. 63-67.

    45. Association of pattern dystrophy with an HTRA1 singlenucleotide polymorphism / T. Jaouni, E. Averbukh, T. Burstyn-Cohen [et al.] / Arch. Ophthalmol. – 2012. – Vol. 130. – P. 987-991. – doi: 10.1001/archophthalmol.2012.1483.

    46. Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports / Y.S. Lee, E.S. Kim, M. Kim [et al.] / BMC Ophthalmol. – 2012. – Vol. 12. – P. 25. – doi: 10.1186/1471-2415-12-25.

    47. Autofluorescence in adult-onset foveomacular vitelliform dystrophy / M.B. Parodi, P. Iacono, M. Pedio [et al.] / Retina. – 2008. – Vol. 28. – P. 801-807.

    48. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options / C.J. Boon, L.I. Van den Born, L. Visser [et al.] / Ophthalmol. – 2013. – Vol. 120. – P. 809-820.

    49. Baran, N.V. Long-term macular function in eyes with central serous chorioretinopathy / N.V. Baran, V.P. Gurlu, H. Esgin / Clin. Exp. Ophthalmol. – 2005. – Vol. 33. – P. 369-372.

    50. Batioglu, F. A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy / F. Batioglu, Y. Ozge, D. Sibel / Turk. J. Ophthalmol. – 2019. – Vol. 49. – P. 226-229. – doi: 10.4274/tjo.galenos.2019.38073.

    51. Baumal, C.R. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27- associated iritis / C.R. Baumal, A. Martidis, S.N. Truong / Arch. Ophthalmol. – 2004. – Vol. 122. – P. 926-928.

    52. Bernell, S. Use your words carefully: What is a chronic disease? / S. Bernell, S.W. Howard / Front. Public Health. – 2016. – Vol. 4. – P. 159.

    53. Biallelic mutation of BEST1 causes a distinct retinopathy in humans / R. Burgess, I.D. Millar, B.P. Leroy [et al.] / Am. J. Hum. Genet. – 2008. – Vol. 82. – P. 19-31. – doi: 10.1016/j.ajhg.2007.08.004.

    54. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature / A.J. Kleinberger, C. Patel, R.M. Lieberman [et al.] / Laryngoscope. – 2011. – Vol. 121. – P. 2034-2037.

    55. Bilateral subfoveal neurosensory retinal detachment associated with MEK inhibitor use for metastatic cancer / T.A. McCannel, B. Chmielowski, R.S. Finn [et al.] / JAMA Ophthalmol. – 2014. – Vol. 132. – P. 1005-1009.

    56. Bujarborua, D. Smokestack leak in central serous chorioretinopathy / D. Bujarborua, P.N. Nagpal, M. Deka / Graefes Arch. Clin. Exp. Ophthalmol. – 2010. – Vol. 248. – P. 339-351.

    57. Burgess, D. Macular Disease Resembling Adult Foveomacular Vitelliform Dystrophy in Older Adults / D. Burgess, R. Olk, L. Uniat / Ophthalmol. – 1987. – Vol. 94, № 4. – P. 362-366. – doi: 10.1016/s0161-6420(87)33438-4.

    58. Butterfly-shaped pigment dystrophy of the fovea / A.F. Deutman, J.D. Van Blommestein, H.E. Henkes [et al.] / Arch. Ophthalmol. – 1970. – Vol. 83. – P. 558-569. – doi: 10.1001/archopht.1970.00990030558006.

    59. Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy / C. Schubert, A. Pryds, S. Zeng [et al.] / Hum. Mutat. – 2014. – Vol. 35, № 7. – P. 859-867. – doi: 10.1002/humu.22551.

    60. Central areolar choroidal dystrophy / C.J. Boon, B.J. Klevering, F.P. Cremers [et al.] / Ophthalmol. – 2009. – Vol. 116. – P. 771-782.

    61. Central serous chorioretinopathy: a pathogenetic model / A. Caccavale, F. Romanazzi, M. Imparato [et al.] / Clin. Ophthalmol. – 2011. – Vol. 5. – P. 239-243.

    62. Central serous chorioretinopathy after epidural corticosteroid injection / T. Iida, R.F. Spaide, S.G. Negrao [et al.] / Am. J. Ophthalmol. – 2001. – Vol. 132. – P. 423-425.

    63. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study / D.-C. Tsai, C.-C. Huang, S.-J. Chen [et al.] / Br. J. Ophthalmol. – 2012. – Vol. 96. – P. 1484-1488.

    64. Central Serous Chorioretinopathy Case-Control Study Group, Risk factors for central serous chorioretinopathy: a case-control study / R. Haimovici, S. Koh, D.R. Gagnon [et al.] / Ophthalmol. – 2004. – Vol. 111. – P. 244-249.

    65. Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects / H.C. Gackle, G.E. Lang, K.A. Freissler [et al.] / Ophthalmol. – 1998. – Vol. 95. – P. 529-533.

    66. Central serous chorioretinopathy in African Americans / U.R. Desai, A.A. Alhalel, T.J. Campen [et al.] / J. Natl. Med. Assoc. – 2003. – Vol. 95. – P. 553-559.

    67. Central serous chorioretinopathy in two families / D.W. Park, H. Schatz, M.M. Gaffney [et al.] / Eur. J. Ophthalmol. – 1998. – Vol. 8. – P. 42-47.

    68. Central serous chorioretinopathy in women / D.A. Quillen, D.M. Gass, R.D. Brod [et al.] / Ophthalmology. – 1996. – Vol. 103. – P. 72-79.

    69. Central serous chorioretinopathy in younger and older adults / R.F. Spaide, L. Campeas, A. Haas [et al.] / Ophthalmol. – 1996. – Vol. 103. – P. 2070-2079.

    70. Central serous chorioretinopathy / M. Wang, I.C. Munch, P.W. Hasler [et al.] / Acta Ophthalmol. – 2008. – Vol. 86. – P. 126-145.

    71. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis / A. Daruich, A. Matet, A. Dirani [et al.] / Prog. Retin. Eye Res. – 2015. – Vol. 48. – P. 82-118. – doi: 10.1016/j.preteyeres.2015.05.003.

    72. Central serous chorioretinopathy resulting in altered vision and color perception after glenohumeral corticosteroid injection / A.P. Hurvitz, K.L. Hodapp, J. Jadgchew [et al.] / Orthopedics. – 2009. – Vol. 32, № 8. – doi: 10.3928/ 01477447-20090624-22.

    73. Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment / B. Nicholson, J. Noble, F. Forooghian, C. Meyerle / Surv. Ophthalmol. – 2013. – Vol. 58, № 2. – P. 103-119.

    74. Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study / J.M. Han, J.-M. Hwang, J.S. Kim [et al.] / Invest. Ophthalmol. Vis. Sci. – 2014. – Vol. 55. – P. 440-445.

    75. Changes of cone photoreceptor mosaic in autosomal recessive bestrophinopathy / A. Nakanishi, S. Ueno, T. Hayashi [et al.] / Retina. – 2020. – Vol. 40, № 1. – P. 181-186. – doi: 10.1097/IAE.0000000000002363.

    76. Characteristics of intra- retinal deposits in acute central serous chorioretinopathy / A.M. Plateroti, M.T. Witmer, S. Kiss, D.J. D'Amico / Clin. Ophthalmol. – 2014. – Vol. 8. – P. 673-676.

    77. Chhablani, J. Multimodal Imaging-Based Central Serous Chorioretinopathy Classification / J. Chhablani, F.B. Cohen / Ophthalmol Retina. – 2020. – Vol. 4, № 11. – P. 1043-1046. – doi: 10.1016/j.oret.2020.07.026. PMID: 33131671

    78. Childhood-onset autosomal recessive bestrophinopathy / A.D. Borman, A.E. Davidson, J. O'Sullivan [et al.] / Arch. Ophthalmol. – 2011. – Vol. 129, № 8. – P. 1088-1093. – doi: 10.1001/archophthalmol.2011.197.

    79. Choroidal thickness in bestvitelliform macular dystrophy / M.B. Parodi, R. Sacconi, P. Iacono [et al.] / Retina. – 2016 – Vol. 36, № 4. – P. 764-769.

    80. Choroidal thickness in central serous chorioretinopathy / S. Kuroda, Y. Ikuno, Y. Yasuno [et al.] / Retina (Phila. Pa.). – 2013. – Vol. 33. – P. 302-308.

    81. Choroidal thickness in healthy Japanese subjects / Y. Ikuno, K. Kawaguchi, T. Nouchi [et al.] / Invest. Ophthalmol. Vis. Sci. – 2010. – Vol. 51. – P. 2173-2176.

    82. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy / F. Hamzah, A. Shinojima, R. Mori [et al.] / BMC Ophthalmol. – 2014. – Vol. 14. – P. 145.

    83. Chung, J.E. Fundus autofluorescence and vitelliform macular dystrophy / J.E. Chung, R.F. Spaide / Arch. Ophthalmol. – 2004. – Vol. 122. – P. 1078-1079.

    84. Clemett, R. Vitelliform dystrophy: long-term observations on New Zealand pedigrees / R. Clemett / Aust. N. Z. J. Ophthalmol. – 1991. – Vol. 19, № 3. – P. 221-227. – doi: 10.1111/j.1442-9071.1991.tb00665.x.

    85. Clinical and imaging findings of pattern dystrophy subtypes; Diagnostic errors and unnecessary treatment in clinical practice / A. Ozkaya, R. Garip, H. Nur Tarakcioglu [et al.] / J. Fr. Ophtalmol. – 2018. – Vol. 41, № 1. – P. 21-29. – doi: 10.1016/j.jfo.2017.06.009.

    86. Clinical and molecular genetic analysis of best vitelliform macular dystrophy / C.J. Boon, T. Theelen, E.H. Hoefsloot [et al.] / Retina. – 2009. – Vol. 29. – P. 835-847.

    87. Clinical characteristics of central serous chorioretinopathy in women / S.L. Perkins, J.E. Kim, J.S. Pollack, P.T. Merrill / Ophthalmol. – 2002. – Vol. 109. – P. 262-266.

    88. Clinical characteristics of subretinal deposits in central serous chorioretinopathy / M. Wang, B. Sander, M. la Cour, M. Larsen / Acta Ophthalmol. Scand. – 2005. – Vol. 83. – P. 691-696.

    89. Combined electrophysiological assessment of the visual system in central serous retinopathy / D. Papakostopoulos, C.D. Hart, R. Cooper, V. Natsikos / Electroencephalogr. Clin. Neurophysiol. – 1984. – Vol. 59. – P. 77-80.

    90. Common spectral domain OCT and electrophysiological findings in different pattern dystrophies / S.R. Hannan, G. de Salvo, A. Stinghe [et al.] / Br. J. Ophthalmol. – 2013. – Vol. 97. – P. 605-610. – doi: 10.1136/bjophthalmol-2011-30125.

    91. Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy / A. Miki, N. Kondo, S. Yanagisawa [et al.] / Ophthalmol. – 2014. – Vol. 121, № 5. – P. 1067-1072.

    92. Comparison of autofluorescence and optical coherence tomography findings in acute and chronic central serous chorioretinopathy / M.Y. Teke, U. Elgin, P. Nalcacioglu-Yuksekkaya [et al.] / Int. J. Ophthalmol. – 2014. – Vol. 7. – P. 350-354.

    93. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinop- athy, and polypoidal choroidal vasculopathy / S.-W. Kim, J. Oh, S.-S. Kwon [et al.] / Retina (Phila. Pa.). – 2011. – Vol. 31. – P. 1904-1911.

    94. Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and agerelated macular degeneration / F. Coscas, N. Puche, G. Coscas [et al.] / Invest. Ophthalmol. Vis. Sci. – 2014. – Vol. 55. – P. 64-69. – doi: 10.1167/iovs.13-12931.

    95. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3 / S.R. Sadda, R. Guymer, F.G. Holz [et al.] / Ophthalmology. – 2018. – Vol. 125, № 4. – P. 537-548. – doi: 10.1016/j.ophtha.2017.09.028.

    96. Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy / O. Yalcinbayir, O. Gelisken, B. Akova-Budak [et al.] / Retina (Phila. Pa.). – 2014. – Vol. 34. – P. 705-712.

    97. Correlation of Visual Function Impairment and Optical Coherence Tomography Findings in Patients with Adult-Onset Foveomacular Vitelliform Macular Dystrophy / G. Querques, A. Bux, R. Prato [et al.] / Am. J. Ophthalmol. – 2008. – Vol. 146, № 1. – P. 135-142.e2. – doi: 10.1016/j.ajo.2008.02.017.

    98. Corticosteroids and central serous chorioretinopathy / C.A. Carvalho-Recchia, L.A. Yannuzzi, S. Negr~ao [et al.] / Ophthalmol. – 2002. – Vol. 109. – P. 1834-1837.

    99. Cystoid macular degeneration in chronic central serous chorioretinopathy / T. Iida, L.A. Yannuzzi, R.F. Spaide [et al.] / Retina (Phila. Pa.) – 2003. – Vol. 23. – P. 1-7.

    100. Dalvin, L. Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States / L. Dalvin, J. Pulido, A. Marmorstein / Ophthalmic. Genetics. – 2016. – Vol. 38, № 2. – P. 143-147. – doi: 10.1080/13816810.2016.1175645.

    101. Defining and measuring chronic conditions: Imperatives for research, policy, program, and practice / R.A. Goodman, S.F. Posner, E.S. Huang [et al.] / Prev. Chronic Dis. – 2013. – Vol. 10. – P. 120239.

    102. Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina / M. Zhao, E. Bousquet, F. Valamanesh [et al.] / Invest. Ophthalmol. Vis. Sci. – 2011. – Vol. 52. – P. 6340-6347.

    103. Diffuse retinal epitheliopathy and central serous chorioretinopathy / D. Cohen, A. Gaudric, G. Coscas [et al.] / Ophtalmol. – 1983. – Vol. 6. – P. 339-349.

    104. Digital indocyanine green videoangiography of central serous chorioretinopathy / D.R. Guyer, L.A. Yannuzzi, J.S. Slakter [et al.] / Arch. Ophthalmol. – 1994. – Vol. 112. – P. 1057-1062.

    105. Eksandh, L. Autoantibodies Against Bestrophin in a Patient With Vitelliform Paraneoplastic Retinopathy and a Metastatic Choroidal Malignant Melanoma / L. Eksandh / Arch. Ophthalmol. – 2008. – Vol. 126, № 3. – P. 432. – doi: 10.1001/archopht.126.3.432.

    106. Elongation of photoreceptor outer segment in central serous chorioretinopathy / H. Matsumoto, S. Kishi, T. Otani, T. Sato / Am. J. Ophthalmol. – 2008. – Vol. 145. – P. 162-168.

    107. En face enhanced- depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy / D. Ferrara, K.J. Mohler, N. Waheed [et al.] / Ophthalmol. – 2014. – Vol. 121. – P. 719-726.

    108. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes / T. Fujiwara, Y. Imamura, R. Margolis [et al.] / Am. J. Ophthalmol. – 2009. – Vol. 148. – P. 445-450.

    109. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study / D.C. Tsai, S.J. Chen, C.C. Huang [et al.] / PLoS One. – 2013. – Vol. 8, № 6. – P. e66858. – doi: 10.1371/journal.pone.0066858.

    110. Errera, M.-H. Pregnancy-associated retinal diseases and their management / M.-H. Errera, R.P. Kohly, L. da Cruz / Surv. Ophthalmol. – 2013. – Vol. 58. – P. 127-142.

    111. Evaluation of central serous retinopathy with en face optical coherence tomography / M.E.J. Van Velthoven, F.D. Verbraak, P.M. Garcia [et al.] / Br. J. Ophthalmol. – 2005. – Vol. 89. – P. 1483-1488.

    112. Extensive intrafamilial and interfamilial phenotypic variation among patients with autosomal dominant retinal dystrophy and mutations in the human RDS/peripherin gene / E. Apfelstedt-Sylla, M. Theischen, K. Ruther [et al.] / Br. J. Ophthalmol. – 1995. – Vol. 79. – P. 28-34. – doi: 10.1136/bjo.79.1.28.

    113. Fernandez, C.F. Central serous chorioretinopathy associated with topical dermal corticosteroids / C.F. Fernandez, A.J. Mendoza, J.F. Arevalo / Retina (Phila. Pa.). – 2004. – Vol. 24. – P. 471-474.

    114. Fluorescein angiographic features of asymptomatic eyes in central serous chorioretinopathy / D. Bujarborua, S. Chatterjee, A. Choudhury [et al.] / Retina (Phila. Pa.) – 2005. – Vol. 25. – P. 422-429.

    115. Francis, P. Genetic and phenotypic heterogeneity in pattern dystrophy / P. Francis / Br. J. Ophthalmol. – 2005. – Vol. 89, № 9. – P. 1115-1119. – doi: 10.1136/ bjo.2004.062695.

    116. Frequency and Clinical Pattern of Vitelliform Macular Dystrophy Caused by Mutations of Interphotoreceptor Matrix IMPG1 and IMPG2 Genes / I. Meunier, G. Manes, B. Bocquet [et al.] / Ophthalmol. – 2014. – Vol. 121, № 12. – P. 2406-2414. – doi: 10.1016/j.ophtha.2014.06.028.

    117. Frequency, Genotype, and Clinical Spectrum of Best Vitelliform Macular Dystrophy: Data From a National Center in Denmark / H. Bitner, P. Schatz, L. Mizrahi-Meissonnier [et al.] / Am. J. Ophthalmol. – 2012. – Vol. 154, № 2. – P. 403-412.e4. – doi: 10.1016/j.ajo.2012.02.036.

    118. Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gen / G. Querques, J. Zerbib, R. Santacroce [et al.] / Mol. Vis. – 2009. – Vol. 15. – P. 2960-2972.

    119. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy / C. Framme, A. Walter, B. Gabler [et al.] / Acta Ophthalmol. Scand. – 2005. – Vol. 83. – P. 161-167.

    120. Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy / H. Matsumoto, S. Kishi, T. Sato, R. Mukai / Am. J. Ophthalmol. – 2011. – Vol. 151. – P. 617.e1e623.e1.

    121. Fundus Autofluorescence, Optical Coherence Tomography and Visual Acuity in Adult-Onset Foveomacular Dystrophy / C. Furino, F. Boscia, N. Cardascia [et al.] / Ophthalmologica. – 2008. – Vol. 222, № 4. – P. 240-244. –doi: 10.1159/000130427

    122. Gass, J. A clinicopathologic study of a peculiar foveomacular dystrophy / J. Gass / Trans. Am. Ophthalmol. – 1974. – Vol. 72. – P. 139-156.

    123. Gass, J. Acute exudative polymorphous vitelliform maculopathy / J. Gass, E. Chuang, H. Granek / Trans. Am. Ophthalmol. Soc. – 1988. – Vol. 86. – P. 354-366.

    124. Gass, J. Pathogenesis of disciform detachment of the neuroepithelium-I: general concepts and classification / J. Gass / Am. J. Ophthalmol. – 1967. – Vol. 63, № 3. – P. 573-585.

    125. Gass, J. Stereoscopic Atlas of Macular Diseases / J. Gass. – Mosby, St Louis, 1997. –162 p.

    126. Gerth, C. Detailed analysis of retinal function and morphology in a patient with autosomal recessive bestrophinopathy (ARB) / C. Gerth, R.J. Zawadzki, J.S. Werner, E. Heon / Doc. Ophthalmol. – 2009. – Vol. 118, № 3. – P. 239-246. – doi: 10.1007/s10633-008-9154-5.

    127. Glacet-Bernard, A. Macular vitelliform degeneration in adults. Retrospective study of a series of 85 patients / A. Glacet-Bernard, G. Soubrane, G. Coscas / J. Fr. Ophtalmol. – 1990. – Vol. 13. – P. 407-420.

    128. Goktas, A. Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy / A. Goktas / Eye (Lond.) – 2014. – Vol. 28. – P. 1431-1436.

    129. Gomez-Sanchez, E. The multifaceted mineralocorticoid eceptor / E. Gomez-Sanchez, C.E. Gomez-Sanchez / Compr. Physiol. – 2014. – Vol. 4. – P. 965-994.

    130. Greaves, A. Adult vitelliform macular degeneration: a clinical spectrum / A. Greaves, J. Sarks, S. Sarks / Aust. N. Z. J. Ophthalmol. – 1990. – Vol. 18. – P. 171-178.

    131. How, A.C.S.W. Angiographic characteristics of acute central se- rous chorioretinopathy in an Asian population / A.C.S.W. How, A.H.C. Koh / Ann. Acad. Med. Singap. – 2006. – Vol. 35. – P. 77-79.

    132. Hsieh, R. Patterned Dystrophies of the Retinal Pigment Epithelium / R. Hsieh, B. Fine, J. Lyons / Arch. Ophthalmol. – 1977. – Vol. 95, № 3. – P. 429-435. – doi: 10.1001/archopht.1977.04450030071006.

    133. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology / J.L. Wilkinson-Berka, G. Tan, K. Jaworski, A.G. Miller / Circ. Res. – 2009. – Vol. 104. – P. 124-133.

    134. Identification of the gene responsible for Best macular dystrophy / K. Petrukhin, M. Koisti, B. Bakall [et al.] / Nat. Genet. – 1998. – Vol. 19, № 3. – P. 241-247. – doi: 10.1038/915.

    135. Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy / I. Barbazetto, K. Dansingani, R. Dolz-Marco [et al.] / Ophthalmol. – 2018. – Vol. 125, № 1. – P. 75-88. – doi: 10.1016/j.ophtha.2017.07.020.

    136. Imamura, Y. Fundus autofluorescence and visual acuity in central serous chorioretinopathy / Y. Imamura, T. Fujiwara, R.F. Spaide / Ophthalmol. – 2011. – Vol. 118. – P. 700-705.

    137. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics / F.C. Delori, C.K. Dorey, G. Staurenghi [et al.] / Invest. Ophthalmol. Vis. Sci. – 1995. – Vol. 36. – P. 718-729.

    138. Increased fundus autofluorescence related to outer retinal disruption / K.B. Freund, S. Mrejen, J. Jung [et al.] / JAMA Ophthalmol. – 2013. – Vol. 131. – P. 1645-1649.

    139. Increased risk of erectile dysfunction among males with central serous chorioretinopathy e a retrospective cohort study / D.-C. Tsai, C.-C. Huang, S.-J. Chen [et al.] / Acta Ophthalmol. – 2013. – Vol. 91. – P. 666-671.

    140. Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy / M. Uyama, H. Matsunaga, T. Matsubara [et al.] / Retina (Phila. Pa.). – 1999. – Vol. 19. – P. 12-21.

    141. Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients / B.A. Lafaut, C. Salati, H. Priem [et al.] / Graefes Arch. Clin. Exp. Ophthalmol. – 1998. – Vol. 236. – P. 513-521.

    142. Indocyanine green videoangiography of older patients with central serous chorioretinopathy / R.F. Spaide, L. Hall, A, Haas [et al.] / Retina (Phila. Pa.). – 1996. – Vol. 16. – P. 203-213.

    143. Intraretinal hyperreflective foci in best vitelliform macular dystrophy / M.B. Parodi, F. Romano, R. Sacconi [et al.] / Retina. – 2018. – Vol. 38, № 12. – P. 2379-2386. – doi: 10.1097/IAE.0000000000001893.

    144. Karadimas, P. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study / P. Karadimas, E.A. Bouzas / Graefes Arch. Clin. Exp. Ophthalmol. – 2004. – Vol. 242. – P. 800-802.

    145. Khairallah, M. Central serous chorioretinopathy, corticosteroids, and uveitis / M. Khairallah, R. Kahloun, I. Tugal-Tutkun / Ocul. Immunol. Inflamm. – 2012. – Vol. 20. – P. 76-85.

    146. Kim, H.C. Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography / H.C. Kim, W.B. Cho, H. Chung / Korean J. Ophthalmol. – 2012. – Vol. 26. – P. 347-354.

    147. Koreen, L. Anti–Retinal Pigment Epithelium Antibodies in Acute Exudative Polymorphous Vitelliform Maculopathy / L. Koreen / Arch. Ophthalmol. – 2011. – Vol. 129, № 1. – P. 23. – doi: 10.1001/archophthalmol.2010.316.

    148. Lanzetta, P. Indocyanine Green Angiography in vitelliform Macular Lesions / P. Lanzetta, G. Virgili, U. Menchini / Ophthalmol. – 1996. – Vol. 210. – P. 189-194.

    149. Laser treatment of diffuse retinal pigment epitheliopathy / L.A. Yannuzzi, J.S. Slakter, S.R. Kaufman, K. Gupta / Eur. J. Ophthalmol. – 1992. – Vol. 2. – P. 103-114.

    150. Late Onset is Common in Best Macular Dystrophy Associated with VMD2 Gene Mutations / A. Renner, H. Tillack, H. Kraus [et al.] / Ophthalmol. – 2005. – Vol. 112, № 4. – P. 586-592.e2. – doi: 10.1016/j.ophtha.2004.10.041.

    151. Leopard spot pattern of yellowish subretinal deposits in central serous chorioretinopathy / T. Iida, R.F. Spaide, A. Haas [et al.] / Arch. Ophthalmol. – 2002. – Vol. 120. – P. 37-42.

    152. Li, X.Q. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students / X.Q. Li, M. Larsen, I.C. Munch / Invest. Ophthalmol. Vis. Sci. – 2011. – Vol. 52. – P. 8438-8441.

    153. Lin, C.F. Best disease presenting as a giant serous pigment epithelial detachment / C.F. Lin, D. Sarraf / Retin Cases Brief Rep. – 2014. – Vol. 8, № 4. – P. 247-250. – doi: 10.1097/ICB.0000000000000101.

    154. Lin, E. Familial central serous choroidopathy / E. Lin, P.G. Arrigg, R.Y. Kim / Graefes Arch. Clin. Exp. Ophthalmol. – 2000. – Vol. 238. – P. 930-931.

    155. Local macular electroretinographic responses in idiopathic central serous chorioretinopathy / Y. Miyake, N. Shiroyama, I. Ota, M. Horiguchi / Am. J. Ophthalmol. – 1988. – Vol. 106. – P. 546-550.

    156. Loss of visual acuity due to central serous retinopathy after steroid injection into the shoulder bursa / A.-A. Kassam, W. White, R.H. Ling [et al.] / J. Shoulder Elb. Surg. – 2011. – Vol. 20. – P. e5e6.

    157. Low-dose aspirin as treatment for central serous chorioretinopathy / A. Caccavale, F. Romanazzi, M. Imparato [et al.] / Clin. Ophthalmol. – 2010. – Vol. 4. – P. 899-903.

    158. Macular vitelliform lesion in desferrioxamine-related retinopathy / M. Genead, G. Fishman, A. Anastasakis [et al.] / Doc. Ophthalmol. – 2010. – Vol. 121, № 2. – P. 161-166. – doi: 10.1007/s10633-010-9236-z.

    159. Margolis, R. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes / R. Margolis, R.F. Spaide / Am. J. Ophthalmol. – 2009. – Vol. 147. – P. 811-815.

    160. Marmor, M.F. Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities / M.F. Marmor, F. Tan / Arch. Ophthalmol. – 1999. – Vol. 117. – P. 184-188.

    161. Masuda's central serous chorioretinopathy (C.S.C.R.) and its somatic investment in Narcissism: our observations on new psychiatric nosography / S.C. Carlesimo, G. Piazzi, C. Leone [et al.] / Clin. Ter. – 2014. – Vol. 165. – P. 27-30.

    162. Mateo-Montoya, A. Helicobacter pylori as a risk factor for central serous chorioretinopathy: literature review / A. Mateo-Montoya, M. Mauget-Fayse / World J. Gastrointest. Pathophysiol. – 2014. – Vol. 5. – P. 355-358.

    163. Mechanisms of ligand specificity of the mineralocorticoid receptor / P.J. Fuller, Y. Yao, J. Yang [et al.] / J. Endocrinol. – 2012. – Vol. 213. – P. 15-24.

    164. Mitarai, K. Three-dimensional optical coherence tomo- graphic findings in central serous chorioretinopathy / K. Mitarai, F. Gomi, Y. Tano / Graefes Arch. Clin. Exp. Ophthalmol. – 2006. – Vol. 244. – P. 1415-1420.

    165. Morphology and functional characreristics in adult vitelliform macular dystrophy / A. Renner, H. Tillack, H. Kraus [et al.] / Retina. – 2004. – Vol. 24, № 6. – P. 929-939. – doi: 10.1097/00006982-200412000-00014.

    166. Mrejen, S. Optical coherence tomography: imaging of the choroid and beyond / S. Mrejen, R.F. Spaide / Surv. Ophthalmol. – 2013. – Vol. 58. – P. 387-429.

    167. Multimodal fundus imaging in Best vitelliform macular dystrophy / D.C. Ferrara, R.A. Costa, S. Tsang [et al.] / Arch. Clin. Exp. Ophthalmol. – 2010. – Vol. 248. – P. 1377-1386.

    168. Multimodal imaging of pigment epithelial detachment: a guide to evaluation / S. Mrejen, D. Sarraf, S.K. Mukkamala, K.B. Freund / Retina (Phila. Pa.). – 2013. – Vol. 33. – P. 1735-1762.

    169. Mutations in IMPG1 cause vitelliform macular dystrophies / G. Manes, I. Meunier, A. Avila-Fernandez [et al.] / Am. J. Hum. Genet. – 2013. – Vol. 93. – P. 571-578.

    170. Mutations in IMPG2, Encoding Interphotoreceptor Matrix Proteoglycan 2, Cause Autosomal-Recessive Retinitis Pigmentosa / D. Bandah-Rozenfeld, R. Collin, E. Banin [et al.] / Am. J. Hum. Genet. – 2010. – Vol. 87, № 2. – P. 199-208. – doi: 10.1016/j.ajhg.2010.07.004.

    171. Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy / J. Wells, J. Wroblewski, J. Keen [et al.] / Nat. Genet. – 1993. – Vol. 3, № 3. – P. 213-218. – doi: 10.1038/ng0393-213.

    172. Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus / C. Boon, M. van Schooneveld, A. den Hollander [et al.] / Br. J. Ophthalmol. – 2007. – Vol. 91, № 11. – P. 1504-1511. – doi: 10.1136/bjo.2007.115659.

    173. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration / F. Kramer, K. White, D. Pauleikhoff [et al.] / Eur. J. Hum. Genet. – 2000. – Vol. 8, № 4. – P. 286-292. – doi: 10.1038/ sj.ejhg.5200447.

    174. Natural course of adult-onset foveomacular vitelliform dystrophy: a spectral-domain optical coherence tomography analysis / G. Querques, R. Forte, L. Querques [et al.] / Am. J. Ophthalmol. – 2011. – Vol. 152. – P. 304-313.

    175. Negi, A. Experimental serous retinal detachment and focal pigment epithelial damage / A. Negi, M.F. Marmor / Arch. Ophthalmol. – 1984. – Vol. 102, № 3. – P. 445-449. – doi: 10.1001/archopht.1984.01040030359038.

    176. Nguyen Dinh Cat, A. Extrarenal effects of aldosterone / A. Nguyen Dinh Cat, F. Jaisser / Curr. Opin.Nephrol. Hypertens. – 2012. – Vol. 21. – P. 147-156.

    177. Nieuwendijk, T.J. Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma / T.J. Nieuwendijk, J.M. Hooymans / Eye (Lond). – 2007. – Vol. 21, № 11. – P. 1436-1437. – doi: 10.1038/sj.eye.6702949.

    178. Nordstrom, S. Hereditary macular degeneration-a population survey in the county of Vasterbotten, Sweden / S. Nordstrom / Hereditas. – 1974. – Vol. 78, № 1. – P. 41-62. – doi: 10.1111/j.1601-5223.1974.tb01427.x.

    179. Novel BEST1 mutations and special clinical characteristics of autosomal recessive bestrophinopathy in Chinese patients / J. Luo, M. Lin, X. Guo [et al.] / Acta Ophthalmol. – 2019. – Vol. 97, № 3. – P. 247-259. – doi: 10.1111/aos.13994.

    180. OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy / M. Battista, E. Borrelli, M. Parravano [et al.] / Br. J. Ophthalmol. – 2020. – Vol. 104, № 10. – P. 1453-1457. – doi: 10.1136/ bjophthalmol-2019-315482.

    181. Odermatt, A. Mineralocorticoid receptors: emerging complexity and functional diversity / A. Odermatt, A.G. Atanasov / Steroids. – 2009. – Vol. 74. – P. 163-171.

    182. Optical coherence tomography angiography in adult-onset foveomacular vitelliform dystrophy / G. Querques, O. Zambrowski, F. Corvi [et al.] / Br. J. Ophthalmol. – 2016. – Vol. 100, № 12. – P. 1724-1730. – doi: 10.1136/ bjophthalmol-2016-308370.

    183. Optical Coherence Tomography Angiography in Central Serous Chorioretinopathy / E. Constanzo, S.Y. Cohen, A. Miere [et al.] / J. Ophthalmol. – 2015. – Vol. 2015. – P. 134783. – doi: 10.1155/2015/134783.

    184. Optical coherence tomography angiography / R.F. Spaide, J.G. Fujimoto, N.K. Waheed [et al.] / Prog. Retin Eye Res. – 2018. – Vol. 64. – P. 1-55. – doi: 10.1016/j.preteyeres.2017.11.003.

    185. Pachychoroid: an inherited condition? / M. Lehmann, E. Bousquet, T. Beydoun, F. Behar-Cohen / Retina (Phila. Pa.). – 2015. – Vol. 35. – P. 10-16.

    186. Pachychoroid disease / C.M.G. Cheung, W.K. Lee, H. Koizumi [et al.] / Eye (Lond). – 2019. – Vol. 33, № 1. – P. 14-33. – doi: 10.1038/s41433-018-0158-4.

    187. Pachychoroid spectrum disease / S. Borooah, P.Y. Sim, S. Phatak [et al.] / Acta Ophthalmologica. – 2020. – doi: 10.1111/aos.14683. – Online ahead of print.

    188. Pang, C.E. Pachychoroid neovasculopathy / C.E. Pang, K.B. Freund / Retina (Phila. Pa.). – 2015. – Vol. 35. – P. 1-9. – doi: 10.1097/IAE.0000000000000331.

    189. Paraneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases / M. Sotodeh, D. Paridaens, J. Keunen [et al.] / Klin. Monbl. Augenheilkd. – 2005. – Vol. 222, № 11. – P. 910-914. – doi: 10.1055/s-2005-858840.

    190. Paraneoplastic Vitelliform Retinopathy: Clinicopathologic Correlation and Review of the Literature / M. Aronow, G. Adamus, M. Abu-Asab [et al.] / Surv. Ophthalmol. – 2012. – Vol. 57, № 6. – P. 558-564. – doi: 10.1016/ j.survophthal.2012.02.004.

    191. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy / L.A. Yannuzzi, J.L. Shakin, Y.L. Fisher, M.A. Altomonte / Ophthalmol. – 1984. – Vol. 91. – P. 1554-1572.

    192. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene / R.G. Weleber, R.E. Carr, W.H. Murphey [et al.] / Arch. Ophthalmol. – 1993. – Vol. 111. – P. 1531-1542. – doi: 10.1001/archopht. 1993.01090110097033.

    193. Piccolino, F.C. Central serous chorioretinopathy and indocyanine green angiography / F.C. Piccolino, L. Borgia / Retina (Phila. Pa.). – 1994. – Vol. 14. – P. 231-242.

    194. Pierce, K.K. Central serous chorioretinopathy associated with the use of ephedra / K.K. Pierce, R.G. Lane / Retin Cases Brief. Rep. – 2009. – Vol. 3. – P. 376-378.

    195. Pizzimenti, J.J. Central serous chorioretinopathy after epidural steroid injection / J.J. Pizzimenti, K.P. Daniel / Pharmacotherapy. – 2005. – Vol. 25. – P. 1141-1146.

    196. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy / L.A. Yannuzzi, K.B. Freund, M. Goldbaum [et al.] / Ophthalmol. – 2000. – Vol. 107. – P. 767-777.

    197. Posterior cystoid retinal degeneration in central serous chorioretinopathy / F.C. Piccolino, R.R. De La Longrais, M. Manea [et al.] / Retina (Phila. Pa.). – 2008. – Vol. 28. – P. 1008-1012.

    198. Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy / C. Wilde, A. Lakshmanan, M. Patel [et al.] / Eye. – 2016. – Vol. 30. – P. 817-824. – doi: 10.1038/eye.2016.46.

    199. Prunte, C. Indocyanine green angiographic findings in central serous chorioretinopathy / C. Prunte / Int. Ophthalmol. – 1995. – Vol. 19. – P. 77-82.

    200. Pseudo-vitelliform macular detachment and cuticular drusen: exclusion of 6 candidate genes / I.A. Barbazetto, N.A. Yannuzzi, C.M. Klais [et al.] / Ophthalmic. Genet. – 2007. – Vol. 28. – P. 192-197. – doi: 10.1080/ 13816810701538596.

    201. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy / S.J. Park, B.H. Kim, K.H. Park, S.J. Woo / Am. J. Ophthalmol. – 2014. – Vol. 158, № 6. – P. 1155-1163.

    202. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography / A. Tsujikawa, Y. Ojima, K. Yamashiro [et al.] / Retina (Phila. Pa.). – 2010. – Vol. 30. – P. 801-809.

    203. Quantitative and qualitative spectral domain optical coherence tomography analysis of sub- retinal deposits in patients with acute central serous retinopathy / G. Landa, J.A. Barnett, P.M.T. Garcia [et al.] / Ophthalmol. – 2013. – Vol. 230. – P. 62-68.

    204. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy / G. Mimoun, V. Caillaux, G. Querques [et al.] / Retina. – 2013. – Vol. 33, № 3. – P. 513-521. – doi: 10.1097/iae. 0b013e3182753adb.

    205. Retinal microvasculature alteration in central serous chorioretinopathy / L. Yu, Y. Shao, Y. Chai [et al.] / Mol. Med. Rep. – 2018. – Vol. 17, № 2. – P. 2335-2340. – doi: 10.3892/mmr.2017.8126.

    206. Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy / F.C. Piccolino, R.R. De La Longrais, M. Manea [et al.] / Retina (Phila. Pa.). – 2008. – Vol. 28. – P. 1146-1150.

    207. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan / D.-C. Tsai, S.-J. Chen, C.-C. Huang [et al.] / Retina (Phila. Pa.). – 2014. – Vol. 34. – P. 1867-1874.

    208. Romero, P. Diffuse retinal pigment epitheliopathy and corticoid ointment topical treatment in a patient with psoriasis / P. Romero, I. Martinez, M. Salvat / J. Fr. Ophtalmol. – 2005. – Vol. 28. – P. 1101-1104.

    209. Roy, R. Multimodal Imaging in a Case of Fundus Pulverulentus / R. Roy, K. Saurabh, D. Shah / Retina. – 2018. – Vol. 38, № 7. – P. e55-e58. – doi: 10.1097/iae.0000000000002213.

    210. Serous Macular Detachment In Best Disease: A Masquerade Syndrome / L. Zatreanu, K.B. Freund, B.C.S. Leong [et al.] / Retina. – 2020. – Vol. 40, № 8. – P. 1456-1470. – doi: 10.1097/IAE.0000000000002659.

    211. Shin, Y.U. Retro-mode imaging for retinal pigment epithelium al- terations in central serous chorioretinopathy / Y.U. Shin, B.R. Lee / Am. J. Ophthalmol. – 2012. – Vol. 154. – P. e4e163.e4.

    212. Slezak, H. Fundus pulverulentus / H. Slezak, K. Hommer / Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1969. – Vol. 178. – P. 176-182. – doi: 10.1007/ bf00414383.

    213. Spaide, R.F. Autofluorescence from the outer retina and subretinal space: hypothesis and review / R.F. Spaide / Retina. – 2008. – Vol. 28. – P. 5-35. – doi: 10.1097/IAE.0b013e318158eca4.

    214. Spaide, R.F. Deposition of yellow submacular material in central serous chorioretinopathy resembling adult-onset foveomacular vitelliform dystrophy / R.F. Spaide / Retina. – 2004. – Vol. 24, № 2. – P. 301-304. – doi: 10.1097/ 00006982-200404000-00019.

    215. Spaide, R.F. Fundus autofluorescence and central serous chorioretinopathy / R.F. Spaide, J.M. Klancnik Jr. / Ophthalmol. – 2005. – Vol. 112. – P. 825-833.

    216. Spectral domain optical coherence tomography features in different stages of best vitelliform macular dystrophy / M.B. Parodi, P. Iacono, F. Romano, F. Bandello / Retina. – 2018. – Vol. 38, № 5. – P. 1041-1046. – doi: 10.1097/IAE. 0000000000001634.

    217. Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy / I. Maruko, T. Iida, A. Ojima, T. Sekiryu / Retina (Phila. Pa.). – 2011. – Vol. 31. – P. 759-765.

    218. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study / H.K. Tewari, R. Gadia, D. Kumar [et al.] / Invest. Ophthalmol. Vis. Sci. – 2006. – Vol. 47. – P. 3474-3478.

    219. Systemic factors associated with central serous chorioretinopathy in Koreans / Y. Eom, J. Oh, S.-W. Kim, K. Huh / Korean J. Ophthalmol. – 2012. – Vol. 26. – P. 260-264.

    220. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy / F.C. Piccolino, R.R. de la Longrais, G. Ravera [et al.] / Am. J. Ophthalmol. – 2005. – Vol. 139. – P. 87-99.

    221. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002 / A.S. Kitzmann, J.S. Pulido, N.N. Diehl [et al.] / Ophthalmol. – 2008. – Vol. 115, № 1. – P. 169-173. – doi: 10.1016/j.ophtha.2007.02.032.

    222. The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon? / N. Farman, E. Maubec, B. Poeggeler [et al.] / Exp. Dermatol. – 2010. – Vol. 19. – P. 100-107.

    223. The optical coherence tomography- ophthalmoscope for examination of central serous chorioretinopathy with precipitates / Y. Kon, T. Iida, I. Maruko, M. Saito / Retina (Phila. Pa.). – 2008. – Vol. 28. – P. 864-869.

    224. The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography / F. Pichi, M. Morara, C. Veronese, A.P. Ciardella / Int. Ophthalmol. – 2018. – Vol. 38, № 3. – P. 975-983. – doi: 10.1007/s10792-017-0547-x.

    225. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene / C.J. Boon, B.J. Kleverin, B.P. Leroy [et al.] / Prog. Retin. Eye Res. – 2009. – Vol. 281. – P. 87-205. – doi: 10.1016/j.preteyeres.2009.04.002.

    226. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene / C. Boon, A. den Hollander, C. Hoyng [et al.] / Prog. Retin Eye Res. – 2008. – Vol. 27, № 2. – P. 213-235. – doi: 10.1016/j.preteyeres.2008.01.002.

    227. Theischen, M. EOG in adult vitelliform macular degeneration, butterfly-shaped pattern dystrophy and Best disease / M. Theischen, H. Schilling, U. Steinhorst / Ophthalmol. – 1997. – Vol. 94. – P. 23063.

    228. Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy / S. Ooto, A. Tsujikawa, S. Mori [et al.] / Graefes Arch. Clin. Exp. Ophthalmol. – 2010. – Vol. 248. – P. 1077-1086.

    229. Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high- speed optical coherence tomography / Y. Ojima, M. Hangai, M. Sasahara [et al.] / Ophthalmol. – 2007. – Vol. 114. – P. 2197-2207.

    230. Transient MEK inhibitor-associated retinopathy in metastatic melanoma / U. Urner-Bloch, M. Urner, P. Stieger [et al.] / Ann. Oncology. – 2014. – Vol. 25, № 7. – P. 1437-1441. – doi: 10.1093/annonc/mdu169.

    231. Variability of subfoveal choroidal thickness measurements in patients with age-related macular degeneration and central serous chorioretinopathy / J.H. Kim, S.W. Kang, J.R. Kim [et al.] / Eye (Lond.). – 2013. – Vol. 27. – P. 809-815.

    232. Verteporfin PDT for non-standard indicationsea review of current literature / W.M. Chan, T.-H. Lim, A. Pece [et al.] / Graefes Arch. Clin. Exp. Ophthalmol. – 2010. – Vol. 248. – P. 613-626.

    233. Vilela, M. Central Serous Chorioretinopathy Classification / M. Vilela, C. Mengue / Pharmaceuticals (Basel). – 2020. – Vol. 14, № 1. – P. 26. – doi: 10.3390/ ph14010026.

    234. von Graefe, A. Ueber centrale recidivierende retinitis / A. von Graefe / Graefes. Arch. Clin. Exp. Ophthalmol. – 1866. – Vol. 12. – P. 211-215.

    235. Warrow, D.J. Pachychoroid pigment epitheliopathy / D.J. Warrow, Q.V. Hoang, K.B. Freund / Retina. – 2013. – Vol. 33, № 8. – P. 1659-1672. – doi: 10.1097/ IAE.0b013e3182953df4.

    236. Weenink, A.C. Familial chronic central serous chorioretinopathy / A.C. Weenink, R.A. Borsje, J.A. Oosterhuis / Ophthalmol. – 2001. – Vol. 215. – P. 183-187.

    237. Yang, L. Choroidal vessel diameter in central serous chorioretinopathy / L. Yang, J.B. Jonas, W. Wei / Acta Ophthalmol. – 2013. – Vol. 91. – P. e358e362.

    238. Yang, L. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy / L. Yang, J.B. Jonas, W. Wei / Invest. Ophthalmol. Vis. Sci. – 2013. – Vol. 54. – P. 4659-4665.

    239. Yannuzzi, L.A. Indocyanine green angiography: a perspective on use in the clinical setting / L.A. Yannuzzi / Am. J. Ophthalmol. – 2011. – Vol. 151. – P. 745.e1e751.e1.

    240. Yannuzzi, L.A. Type-A behavior and central serous chorioretinopathy / L.A. Yannuzzi / Retina (Phila. Pa.). – 1987. – Vol. 7. – P. 111-131.

    241. Yannuzzi, L.A. Type A behavior and central serous chorioretinopathy / L.A. Yannuzzi / Trans. – 1986. – Vol. 84. – P. 799-845.